Abstract
Murine models have suggested that CD8+ T-cell responses peak early in acute viral infections and are not sustained, but no evidence for humans has been available. To address this, we longitudinally analyzed the CD8+ T-cell response to human parvovirus B19 in acutely infected individuals. We observed striking CD8+ T-cell responses, which were sustained or even increased over many months after the resolution of acute disease, indicating that CD8+ T cells may play a prominent role in the control of parvovirus B19 and other acute viral infections of humans, including potentially those generated by live vaccines.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acute Disease
-
Adult
-
Amino Acid Sequence
-
Animals
-
Antigens, Viral / genetics
-
CD8-Positive T-Lymphocytes / immunology*
-
Capsid Proteins / genetics
-
Capsid Proteins / immunology
-
Epitopes / genetics
-
Female
-
Humans
-
Mice
-
Middle Aged
-
Molecular Sequence Data
-
Parvoviridae Infections / immunology*
-
Parvovirus B19, Human* / genetics
-
Parvovirus B19, Human* / immunology
-
Prospective Studies
-
Time Factors
-
Viral Nonstructural Proteins / genetics
-
Viral Nonstructural Proteins / immunology
Substances
-
Antigens, Viral
-
Capsid Proteins
-
Epitopes
-
Viral Nonstructural Proteins
-
capsid protein VP2, parvovirus B19